STERIS Free Cash Flow 2010-2024 | STE
STERIS annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- STERIS free cash flow for the quarter ending June 30, 2024 was 195.66, a year-over-year.
- STERIS free cash flow for the twelve months ending June 30, 2024 was , a year-over-year.
- STERIS annual free cash flow for 2024 was $0.62B, a 51.46% increase from 2023.
- STERIS annual free cash flow for 2023 was $0.41B, a 2.65% increase from 2022.
- STERIS annual free cash flow for 2022 was $0.399B, a 11.52% decline from 2021.
| STERIS Annual Free Cash Flow | |
|---|---|
| 2024 | 620.33 |
| 2023 | 409.57 |
| 2022 | 398.99 |
| 2021 | 450.95 |
| 2020 | 380.20 |
| 2019 | 355.36 |
| 2018 | 294.27 |
| 2017 | 256.03 |
| 2016 | 129.11 |
| 2015 | 161.61 |
| 2014 | 128.04 |
| 2013 | 140.44 |
| 2012 | 82.73 |
| 2011 | 41.60 |
| 2010 | 183.97 |
| 2009 | 145.84 |
| STERIS Quarterly Free Cash Flow | |
|---|---|
| 2024-06-30 | 195.66 |
| 2024-03-31 | 620.33 |
| 2023-12-31 | 457.01 |
| 2023-09-30 | 284.69 |
| 2023-06-30 | 214.53 |
| 2023-03-31 | 409.57 |
| 2022-12-31 | 262.79 |
| 2022-09-30 | 138.19 |
| 2022-06-30 | 117.10 |
| 2022-03-31 | 398.99 |
| 2021-12-31 | 300.30 |
| 2021-09-30 | 135.78 |
| 2021-06-30 | 41.25 |
| 2021-03-31 | 450.95 |
| 2020-12-31 | 337.71 |
| 2020-09-30 | 185.60 |
| 2020-06-30 | 67.40 |
| 2020-03-31 | 380.20 |
| 2019-12-31 | 238.06 |
| 2019-09-30 | 162.04 |
| 2019-06-30 | 59.56 |
| 2019-03-31 | 355.36 |
| 2018-12-31 | 252.91 |
| 2018-09-30 | 169.70 |
| 2018-06-30 | 75.85 |
| 2018-03-31 | 294.27 |
| 2017-12-31 | 216.44 |
| 2017-09-30 | 144.03 |
| 2017-06-30 | 44.17 |
| 2017-03-31 | 256.03 |
| 2016-12-31 | 181.97 |
| 2016-09-30 | 119.40 |
| 2016-06-30 | 49.49 |
| 2016-03-31 | 129.11 |
| 2015-12-31 | 22.90 |
| 2015-09-30 | 39.58 |
| 2015-06-30 | 17.66 |
| 2015-03-31 | 161.61 |
| 2014-12-31 | 109.27 |
| 2014-09-30 | 69.18 |
| 2014-06-30 | 23.09 |
| 2014-03-31 | 128.04 |
| 2013-12-31 | 82.13 |
| 2013-09-30 | 32.94 |
| 2013-06-30 | 10.96 |
| 2013-03-31 | 140.44 |
| 2012-12-31 | 117.09 |
| 2012-09-30 | 66.98 |
| 2012-06-30 | 45.74 |
| 2012-03-31 | 82.73 |
| 2011-12-31 | 58.60 |
| 2011-09-30 | 26.09 |
| 2011-06-30 | -3.61 |
| 2011-03-31 | 41.60 |
| 2010-12-31 | 28.31 |
| 2010-09-30 | 29.31 |
| 2010-06-30 | 17.29 |
| 2010-03-31 | 183.97 |
| 2009-12-31 | 129.40 |
| 2009-09-30 | 74.37 |
| 2009-06-30 | 24.44 |
| 2009-03-31 | 145.84 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $21.985B | $5.139B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $206.837B | 25.23 |
| Intuitive Surgical (ISRG) | United States | $191.293B | 100.01 |
| Alcon (ALC) | Switzerland | $42.858B | 28.68 |
| Edwards Lifesciences (EW) | United States | $38.815B | 24.65 |
| IQVIA Holdings (IQV) | United States | $38.763B | 21.36 |
| IDEXX Laboratories (IDXX) | United States | $34.892B | 41.09 |
| DexCom (DXCM) | United States | $29.037B | 43.73 |
| Waters (WAT) | United States | $22.907B | 33.87 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.643B | 0.00 |
| Hologic (HOLX) | United States | $18.526B | 19.55 |
| Sysmex ADR (SSMXY) | Japan | $12.594B | 39.49 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.447B | 12.78 |
| Globus Medical (GMED) | United States | $11.296B | 28.77 |
| Teleflex (TFX) | United States | $9.083B | 14.49 |
| Penumbra (PEN) | United States | $9.066B | 88.81 |
| Masimo (MASI) | United States | $8.612B | 41.67 |
| Glaukos (GKOS) | United States | $7.919B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.986B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.592B | 26.02 |
| TransMedics (TMDX) | United States | $3.068B | 97.25 |
| Inari Medical (NARI) | United States | $3.003B | 0.00 |
| Veracyte (VCYT) | United States | $2.964B | 88.93 |
| LivaNova (LIVN) | United Kingdom | $2.878B | 16.61 |
| Nihon Kohden (NHNKY) | Japan | $2.557B | 19.42 |
| Elekta AB (EKTAY) | Sweden | $2.252B | 18.35 |
| Tandem Diabetes Care (TNDM) | United States | $2.043B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.914B | 10.00 |
| RxSight (RXST) | United States | $1.832B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.316B | 0.00 |
| Artivion (AORT) | United States | $1.162B | 77.03 |
| OPKO Health (OPK) | United States | $1.099B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.091B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.915B | 15.55 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.735B | 0.00 |
| IRadimed (IRMD) | United States | $0.722B | 39.01 |
| SiBone (SIBN) | United States | $0.652B | 0.00 |
| Paragon 28 (FNA) | United States | $0.627B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.610B | 14.39 |
| Pacific Biosciences Of California (PACB) | United States | $0.601B | 0.00 |
| AxoGen (AXGN) | United States | $0.584B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.582B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.501B | 0.00 |
| CVRx (CVRX) | United States | $0.383B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.383B | 25.71 |
| Tactile Systems Technology (TCMD) | United States | $0.378B | 20.45 |
| Delcath Systems (DCTH) | United States | $0.310B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.307B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.215B | 0.00 |
| NeuroPace (NPCE) | United States | $0.208B | 0.00 |
| Accuray (ARAY) | United States | $0.192B | 0.00 |
| Nevro (NVRO) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.157B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.117B | 17.44 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| 908 Devices (MASS) | United States | $0.101B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.068B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| InspireMD (NSPR) | Israel | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.054B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.049B | 0.00 |
| Envoy Medical (COCH) | United States | $0.041B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.034B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.032B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| Neuronetics (STIM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |